The European Cancer Patient Coalition participates in the EU 3rd Health Programme, as well as several European Union Research and Innovation framework programmes: this includes the Seventh Framework Programme (FP7) and Innovative Medicines Initiatives  under the current Horizon 2020 (H2020) programme.

ECPC’s participation in calls takes into account the basic principle of incorporating European added value into current members’ activities. We promote the concept of patients as co-researchers and the need for research projects to focus on patients’ priorities, and aim to influence European Union (EU) research priorities to match those of cancer patients’ needs.